Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: A combined analysis of 3 phase 2/3 clinical trials

Michael P. Manns, Jonathan Mccone, Mitchell N. Davis, Lorenzo Rossaro, Eugene Schiff, Mitchel L. Shiffman, Bruce Bacon, Marc Bourliere, Mark S. Sulkowski, Savino Bruno, Luis Balart, Jean Pierre Bronowicki, Paul Kwo, Fred Poordad, Franco Felizarta, K. Rajender Reddy, Frans A. Helmond, Heather L. Sings, Lisa D. Pedicone, Margaret BurroughsClifford A. Brass, Janice K. Albrecht, John M. Vierling

Research output: Contribution to journalArticle

9 Scopus citations

Fingerprint Dive into the research topics of 'Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: A combined analysis of 3 phase 2/3 clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences